Benda Pharmaceutical, Inc. Makes CNNMoney.com Debut as Subject of Investor Ideas Article

HUBEI PROVINCE, CHINA--(Marketwire - October 24, 2007) - Benda Pharmaceutical, Inc. (“Benda” or the “Company”) (OTCBB: BPMA), a China-based pharmaceutical company producing traditional Chinese and conventional medicines, as well as Gendicine®, the world’s first commercialized gene therapy medicine for the treatment of cancer, announced today it is the subject of an article appearing now on CNNMoney.com. The article, which poses the question, “Pharmaceutical and Biotech Stocks -- Is Gene Therapy the Next Major Breakthrough in Cancer Treatment?” can be viewed by clicking here.

MORE ON THIS TOPIC